ANNETTE FOX LEUKAEMIA RESEARCH FUND
The Annette Fox Leukaemia Research Fund has as its objectives, the relief of sickness and in particular leukaemia, lymphoma, and other related haematological diseases by implementing the improvement of patient facilities and promoting research into the cause, treatment and cure of such conditions in Bradford and surrounding districts.
Financial health, per its FY2025 accounts
The accounts state that the charity reported a net expenditure of £34,421.25 for the year, resulting in a decrease in total unrestricted funds from £633,085.64 to £598,664.39. The trustees confirm the charity has adequate resources to continue in operational existence for the foreseeable future, citing stabilized income and investment dividends despite ongoing pandemic impacts on fundraising.
What the accounts disclose
Trustees
- JONATHAN PETER BENTLEYchair
- Andrea Jayne Jones
- Christine PARAPIA
- DR Ann Cuthbert
- Dr ADRIAN WILLIAMS
- Janice McDevitt Lee
- MICHAEL HEATON
- Sarah-Elizabeth Lazar
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/03/2025 | £47k | £82k |
| 31/03/2024 | £22k | £78k |
| 31/03/2023 | £32k | £92k |
| 31/03/2022 | £17k | £79k |
| 31/03/2021 | £11k | £121k |
Common questions
Is ANNETTE FOX LEUKAEMIA RESEARCH FUND financially healthy?
Per its FY2025 accounts: The accounts state that the charity reported a net expenditure of £34,421.25 for the year, resulting in a decrease in total unrestricted funds from £633,085.64 to £598,664.39. The trustees confirm the charity has adequate resources to continue in operational existence for the foreseeable future, citing stabilized income and investment dividends despite ongoing pandemic impacts on fundraising.